XFOR — X4 Pharmaceuticals
Median target
$11.5
calls from the last 12 months
Implied return
+228.6%
median target vs. price
Coverage
4 analysts · 5 calls
updated in the last 12 months
Consensus
4/0/0+4 net
Buy / Hold / Sell
Which analysts are behind XFOR's consensus?
See every current rating, price target and the analysts' track records for X4 Pharmaceuticals — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 4 analysts with calls on XFOR updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
XFOR elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-08-12 | Insiders | Craig Adam RExecutive Chairman | Insider sale | 47.4K sh @ $4.44 | $211K |
| 2026-08-12 | Insiders | Volpone JohnPresident | Insider sale | 24.6K sh @ $4.44 | $109K |
More: insider activity · executive branch · trending